| 注册
首页|期刊导航|内科理论与实践|基于嵌合抗原受体细胞疗法在自身免疫性疾病中应用的前景

基于嵌合抗原受体细胞疗法在自身免疫性疾病中应用的前景

高洁

内科理论与实践2024,Vol.19Issue(6):363-366,4.
内科理论与实践2024,Vol.19Issue(6):363-366,4.DOI:10.16138/j.1673-6087.2024.06.02

基于嵌合抗原受体细胞疗法在自身免疫性疾病中应用的前景

Prospects and challenges of applying chimeic antigen receptor cell therapy in autoimmune diseases

高洁1

作者信息

  • 1. 海军军医大学第一附属医院风湿免疫科,上海 200433
  • 折叠

摘要

Abstract

In recent years,chimeric antigen receptor(CAR)cell therapy,as an emerging immunotherapy method,has achieved significant results in the field of hematological cancer treatment.However,applying CAR cell therapy to autoimmune diseases remains a relatively novel and challenging method.Autoimmune diseases are caused by an individual's immune system mistakenly attacking their own tissues,and their complex etiology and diverse symptoms make traditional treatment methods and biologics still unable to meet clinical needs.CAR cell therapy,using engineering T cells or other immune cells to recognize and kill specific antigens,is highly targeted and durable,which providing new hope for the treatment of autoimmune diseases.This article systematically reviews the latest research progress and challenges of using CAR cell therapy in the treatment of autoimmune diseases,such as safety,immune response issues,and difficulties in clinical application.

关键词

嵌合抗原受体/细胞疗法/自身免疫性疾病/安全性/临床应用

Key words

Chimeric antigen receptor/Cell therapy/Autoimmune diseases/Safety/Clinical application

分类

医药卫生

引用本文复制引用

高洁..基于嵌合抗原受体细胞疗法在自身免疫性疾病中应用的前景[J].内科理论与实践,2024,19(6):363-366,4.

内科理论与实践

OACSTPCD

1673-6087

访问量0
|
下载量0
段落导航相关论文